All News #Library
Biotech
Alpine Immune Sciences, Janux said to be looking at possible sales — reports
10 Apr 2024 //
ENDPTS
Alpine Immune Sciences Shares Clinical Data on Povetacicept
09 Apr 2024 //
BUSINESSWIRE
Alpine to Present Updated Clinical Data for Povetacicept in WCN 2024
01 Apr 2024 //
BUSINESSWIRE
Alpine Presents New Translational Data on Povetacicept at the EU Meeting 2024
21 Mar 2024 //
BUSINESSWIRE
Alpine Immune Sciences Announces Amendment of Acazicolcept Option with AbbVie
21 Dec 2023 //
BUSINESSWIRE
Alpine Immune Sciences Presents New Translational Data on Povetacicept
15 Nov 2023 //
BUSINESSWIRE
Alpine Immune Presents Data on Acazicolcept in Systemic Lupus Erythematosus
13 Nov 2023 //
PRESS RELEASE
Alpine Immune Presents New Preclinical Data on Povetacicept in Myasthenia Gravis
03 Nov 2023 //
BUSINESSWIRE
Alpine Immune Sciences Presents Initial Clinical Data on Povetacicept
02 Nov 2023 //
BUSINESSWIRE
Alpine Immune Sciences to Present New Translational Data on Povetacicept
30 Oct 2023 //
BUSINESSWIRE
Alpine Immune Sciences to Present Initial Clinical Data on Povetacicept
13 Oct 2023 //
BUSINESSWIRE
Alpine Immune Sciences Presents First Preclinical Data for Povetacicept
12 Sep 2023 //
BUSINESSWIRE
Alpine Immune to Present Data for Povetacicept in Myasthenia Gravis
05 Sep 2023 //
BUSINESSWIRE
Alpine Immune Sciences to Present Povetacicept Phase 1 Study Data
16 Mar 2023 //
BUSINESSWIRE

Market Place
Sourcing Support